Cilazapril

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) that is used for the treatment of hypertension and congestive heart failure. It was patented in 1980 and came into medical use in 1988. Cilazapril is available in countries such as Switzerland, Italy, and New Zealand.

Etymology

The name "Cilazapril" is derived from the systematic (IUPAC) name which is (2S,4S)-1-[[2-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid, 1-ethyl ester. The "Cila" part of the name is taken from the first four letters of the company that first synthesized it, Cilag. The "pril" ending is a common ending for ACE inhibitors.

Medical Uses

Cilazapril is used for the treatment of hypertension and congestive heart failure. It works by inhibiting the angiotensin-converting enzyme which is involved in the regulation of blood pressure.

Side Effects

Common side effects of Cilazapril include dizziness, headache, fatigue, and cough. Serious side effects may include angioedema, kidney problems, and high blood potassium.

Related Terms

• ACE inhibitors
• Hypertension
• Congestive heart failure

See Also

• List of ACE inhibitors
• Angiotensin II receptor antagonist

Cilazapril Resources
Latest articles Most recent articles Ongoing trials	Wikipedia